Navigation Links
Abaxis, Inc. to Present at the Fifth Annual Sidoti & Company Emerging Growth Conference
Date:1/15/2008

UNION CITY, Calif., Jan. 15 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Clint Severson, CEO and President, will present at the Fifth Annual Sidoti & Company Emerging Growth Conference on Wednesday, January 23, 2008 at 11:00 a.m. ET. The conference will be held at The Ritz-Carlton, Palm Beach Florida.

About Abaxis

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.

Contact:

Clint Severson Lytham Partners, LLC

Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum

ABAXIS, Inc. 602-889-9700

510-675-6500


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. A New Book on Sexual Medicine Calls Attention to The Couple and Presents State-of-the Art Treatments for Sexual Dysfunction
2. GSI to Present at Upcoming Investor Growth Conferences
3. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
4. Isolagen Inc. to Present at the 26th Annual JPMorgan Healthcare Conference
5. Emageon to Present at the 26th Annual JPMorgan Healthcare Conference
6. Warner Chilcott to Present at the 26th Annual JPMorgan Healthcare Conference
7. Covance to Present at 26th Annual JPMorgan Healthcare Conference
8. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
9. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
10. DaVita Inc. to Present at JPMorgan Healthcare Conference
11. Hologic to Present at the 26th Annual JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... 2017 , ... East Los Angeles dentist, Ramin Assili DDS , comments ... happens to a woman during pregnancy can have profound effects on a developing fetus, ... on a baby’s long-term health. This study, which was performed at the University of ...
(Date:6/26/2017)... Torrance, CA (PRWEB) , ... June 26, 2017 , ... ... treatments. Smile aesthetics can be one of the most noticeable aspects of a person’s ... approachable. While not everyone is born with beautiful, balanced teeth, everyone can have the ...
(Date:6/26/2017)... ... June 26, 2017 , ... ... & Sexual Medicine Specialists, in collaboration with the Fertility Center of California, is ... care: PESA (percutaneous epidydimal sperm aspiration) and TESA (percutaneous testicular sperm extraction). These ...
(Date:6/26/2017)... SALISBURY, MD. (PRWEB) , ... June 26, 2017 ... ... their crop, according to a recent review of government data released by the ... continuous improvement in management practices, Maryland’s soybean farmers have increased their productivity on ...
(Date:6/26/2017)... Lake Tahoe, CA (PRWEB) , ... June 26, 2017 , ... ... seeking 10,000 qualified mental health professionals in every state across the country to join ... an easy and rewarding way for therapists to reach a substantially greater number of ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)... GAITHERSBURG, Md. , June 7, 2017  Novavax, Inc., ... the second of two Phase 2 trials of its RSV ... women of child bearing age have been published in the ... this publication have been shared in prior scientific conferences). The ... trial in April 2014. Novavax is developing the RSV F ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: